Sreedhar Subramanian (Sreedar Subramanian, S Subramanian)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Binding Protein

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

BMJ open gastroenterology

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Gerum Gashaw Gebeyehu, Giacomo Broglio, Eleanor Liu, Jimmy K Limdi, Christian Selinger, Joseph Fiske, Violeta Razanskaite, Philip J Smith, Paul K Flanagan, Sreedhar Subramanian
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients. Inflammatory bowel diseases (2024)
Gerum Gashaw Gebeyehu, Joseph Fiske, Eleanor Liu, Jimmy K Limdi, Giacomo Broglio, Christian Selinger, Violeta Razsanskaite, Philip J Smith, Paul K Flanagan, Sreedhar Subramanian
Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients. Digestive diseases and sciences (2022)
Timothy Raine, Holly Pavey, Wendi Qian, Gordon William Moran, Sreedhar Subramanian, Lizzie Swaby, Simon P L Travis, Shahida Din, Peter M Irving, James O Lindsay, Miles Parkes, Nicholas Alexander Kennedy
Establishment of a validated central reading system for ileocolonoscopy in an academic setting. Gut 71 (4) (2022)
Vinoth Nadesalingam, Sreedhar Subramanian
Editorial: intravenous to subcutaneous vedolizumab-switch without glitch! Alimentary pharmacology & therapeutics 56 (2) (2022)
Sreedhar Subramanian, Jonathan M Rhodes, Joseph M Taylor, Anna M Milan, Steven Lane, Martin Hewison, Rene F Chun, Andrea Jorgensen, Paul Richardson, Darshan Nitchingham, Joseph Aslan, Maya Shah, Coonoor R Chandrasekar, Amanda Wood, Mike Beadsworth, Munir Pirmohamed
Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patients. The American journal of clinical nutrition 115 (5) (2022)
Shaji Sebastian, Jonathan P Segal, Sreedhar Subramanian, Thomas Edward Conley, Haidee Aleman Gonzalez, Alexandra J Kent, Aamir Saifuddin, Lucy C Hicks, Shameer J Mehta, Neeraj Bhala, Matthew James Brookes, Christopher Andrew Lamb, Nicholas Alexander Kennedy, null null, Gareth J Walker
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study. BMJ open gastroenterology 9 (1) (2022)
Philip J Smith, Lisa Critchley, Daniel Storey, Belle Gregg, June Stenson, Andrew Kneebone, Tracy Rimmer, Stevena Burke, Shamas Hussain, Wan Yi Teoh, Stephan Vazeille, Solange Serna, Alan Steel, Edmund Derbyshire, Paul Collins, Martyn Dibb, Paul Flanagan, Christopher Sj Probert, Ajay Mark Verma, Sreedhar Subramanian
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. Journal of Crohn's & colitis 16 (9) (2022)
Aamir Saifuddin, Alexandra J Kent, Shameer J Mehta, Lucy C Hicks, Haidee Aleman Gonzalez, Jonathan P Segal, Matthew James Brookes, Sreedhar Subramanian, Neeraj Bhala, Thomas Edward Conley, Kamal V Patel, null null, Christopher Andrew Lamb, Gareth J Walker, Nicholas Alexander Kennedy, Shaji Sebastian
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study. Alimentary pharmacology & therapeutics 56 (10) (2022)
Christopher Andrew Lamb, Shaji Sebastian, Alexandra J Kent, Jonathan P Segal, Haidee Aleman Gonzalez, Matthew James Brookes, Shameer J Mehta, Sreedhar Subramanian, Neeraj Bhala, Lucy C Hicks, Thomas Edward Conley, Kamal V Patel, Gareth J Walker, Nicholas Alexander Kennedy, null null
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Alimentary pharmacology & therapeutics 53 (11) (2021)
Tristan Townsend, Sreedhar Subramanian
Letter: propensity score-handle with care. Authors' reply. Alimentary pharmacology & therapeutics 53 (2) (2021)
Tristan Townsend, Sreedhar Subramanian
Editorial: vedolizumab in inflammatory bowel diseases-less is more? Alimentary pharmacology & therapeutics 53 (3) (2021)
Darshan Nitchingham, Thomas Edward Conley, Vijay Chidambaram, Sreedhar Subramanian
Unexpected cause of dysphagia. BMJ case reports 14 (4) (2021)
Edward Britton, Paul Richardson, Ibrahim Mian, Thomas Conley, David Byrne, Holly Boyd, Connor Doherty, Sandipika Gupta, Sundas Butt, Sreedhar Subramanian
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Alimentary pharmacology & therapeutics 52 (8) (2020)
Shaji Sebastian, Nicholas A Kennedy, Sreedhar Subramanian, Tim Raine
Editorial: accelerated infliximab induction-it's time to settle the debate! Authors' reply. Alimentary pharmacology & therapeutics 50 (9) (2020)
Joseph Aslan, Thomas E Conley, Fiona Campbell, Philip J Smith, Frances McNicol, Timothy Andrews, Sreedhar Subramanian
Recurrent colonic polyps. Gut (2020)
Tristan Townsend, Sreedhar Subramanian
Editorial: endoscopic inflammation in ileoanal pouches-does it really matter? Alimentary pharmacology & therapeutics 51 (1) (2020)
Tristan Townsend, Violeta Razanskaite, Susanna Dodd, Daniel Storey, Stephanie Michail, James Morgan, Michael Davies, Douglas Penman, Christopher Watters, Mira Swaminathan, Joseph Sabine, Adam Chapman, Philip J Smith, Paul K Flanagan, Ian Reilly, Keith Bodger, Sreedhar Subramanian
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease. Alimentary pharmacology & therapeutics 52 (8) (2020)
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose A Kenny
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Alimentary pharmacology & therapeutics 51 (12) (2020)
Tony B Yu, Susanna Dodd, Lu-Gang Yu, Sreedhar Subramanian
Serum galectins as potential biomarkers of inflammatory bowel diseases. PloS one 15 (1) (2020)
Shaji Sebastian, Sally Myers, Konstantinos Argyriou, Gayle Martin, Louis Los, Joseph Fiske, Ravi Ranjan, Benjamin Cooper, Vivek Goodoory, Hey-Long Ching, NishaniLalanthika Jayasooriya, Johanne Brooks, Anjan Dhar, Achut H Shenoy, Jimmy K Limdi, Jeffrey Butterworth, Patrick B Allen, Sunil Samuel, Gordon William Moran, Richard Shenderey, Gareth Parkes, Alan Lobo, Nicholas A Kennedy, Sreedhar Subramanian, Tim Raine
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis. Alimentary pharmacology & therapeutics 50 (6) (2020)
David Sawbridge, Sreedhar Subramanian
Editorial: the IBD-disability index-ready for prime time? Alimentary pharmacology & therapeutics 47 (2) (2019)
David Sawbridge, Sreedhar Subramanian
Editorial: mitigating primary nonresponse to infliximab-are we better equipped now? Alimentary pharmacology & therapeutics 47 (3) (2019)